Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK ‐Based Approaches
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70150 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Moritz Walter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Boehringer Ingelheim Pharma GmbH & Co. KG, Medicinal Chemistry, Computational Chemistry, Biberach, Germany. Hauptthemen laut MEDLINE: Machine Learning, Models, Biological, Pharmacokinetics. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A successful drug needs to combine several properties including high potency and good pharmacokinetic (PK) properties to sustain efficacious plasma concentration over time. To estimate required doses for preclinical animal efficacy models or for the clinics, in vivo PK studies need to be conducted. Although the prediction of ADME properties of compounds using machine learning (ML) models based on chemical structures is well established in drug discovery, the prediction of complete plasma concentration–time profiles has only recently gained attention. In this study, we systematically compare various approaches that integrate ML models with empiric or mechanistic PK models to predict PK profiles in rats after intravenous administration prior to synthesis. More specifically, we compare a standard noncompartmental analysis (NCA)‐based approach (prediction of CL and V ss ), a pure ML approach (non‐mechanistic PK description), a compartmental modeling approach, and a physiologically based pharmacokinetic (PBPK) approach. Our study based on internal preclinical data shows that the latter three approaches yield PK profile predictions of comparable accuracy across a large data set (evaluated as geometric mean fold errors for each profile of over 1000 small molecules). In summary, we demonstrate the improved ability to prioritize drug candidates with desirable PK properties prior to synthesis with ML predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boehringer Ingelheim Pharma GmbH & Co. KG, Medicinal Chemistry, Computational Chemistry, Biberach, Germany.
- Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Preclinical PKPD Modelling and Data & Digital Sciences, Biberach, Germany.
- ESQlabs GmbH, Saterland, Germany.
ORCID-Profile: Moritz Walter, Ghaith Aljayyoussi, Hermann Rapp, Miha Skalic, Jens M Borghardt, Lina Humbeck
Zitieren
APA
Walter, M., Aljayyoussi, G., Gerner, B., Rapp, H., Tautermann, C. S., Balazki, P., Skalic, M., Borghardt, J. M., & Humbeck, L. (2025). Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK ‐Based Approaches. Clinical and Translational Science. https://doi.org/10.1111/cts.70150
Vancouver
Walter M, Aljayyoussi G, Gerner B, Rapp H, Tautermann CS, Balazki P, et al. Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK ‐Based Approaches. Clinical and Translational Science. 2025. doi:10.1111/cts.70150
BibTeX
@article{Walter2025,
author = {Walter, Moritz and Aljayyoussi, Ghaith and Gerner, Bettina and Rapp, Hermann and Tautermann, Christofer S and Balazki, Pavel and Skalic, Miha and Borghardt, Jens M and Humbeck, Lina},
title = {Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK ‐Based Approaches},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70150}
}
EUVIMED